Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22344789 | 1.00 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL1064815 | 0.83 | ALDH1A1 (0.44) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL15362875 | 0.83 | ALDH1A1 (0.44) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL22344785 | 0.83 | ALB (0.49) | ALDH1A1SMN1; SMN2KDM4EFOLH1 | |
| SCHEMBL7131820 | 0.76 | ALDH1A1 (0.55) | ALDH1A1SMN1; SMN2CACNA1H | |
| SCHEMBL15300102 | 0.76 | DRD2 (0.40) | ALDH1A1KMT2ASMN1; SMN2TSHRKDM4E | |
| SCHEMBL25039413 | 0.76 | ALDH1A1 (0.40) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL7128542 | 0.74 | ALDH1A1 (0.67) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL15362287 | 0.74 | ITGB3 (0.41) | ALDH1A1KMT2ASMN1; SMN2TSHRLMNA | |
| SCHEMBL10036356 | 0.74 | ITGB3 (0.41) | ALDH1A1KMT2ASMN1; SMN2LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230127047-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | ANTAROS MEDICAL AB (SE) | 2023-04-27 | — | — | US | disclosed |
| CN-108697767-B | Selective glucagon receptor agonists comprising a chelating moiety for imaging purposes | 安塔罗斯医疗公司 | 2022-04-15 | — | — | CN | disclosed |
| EP-3389697-B1 | SELECTIVE GLUCAGON RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING PURPOSES | ANTAROS MEDICAL AB (SE) | 2020-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230127047-A1 | SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES | GIPR, GRPR, GLP1R | ALDH1A1 4537/4885KMT2A 3476/4885SMN1; SMN2 3206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.